These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9225371)

  • 1. Recurrent paroxysmal episodes characterized by perceptual alteration in three schizophrenic patients on neuroleptic medication.
    Higuchi H; Shimizu T; Hishikawa Y
    Psychiatry Clin Neurosci; 1997 Jun; 51(3):99-101. PubMed ID: 9225371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biperiden and haloperidol plasma levels and extrapyramidal side effects in schizophrenic patients.
    Meszaros K; Lenzinger E; Hornik K; Schönbeck G; Hatzinger R; Langer G; Sieghart W; Aschauer HN
    Neuropsychobiology; 1997; 36(2):69-72. PubMed ID: 9267855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The syndromes of oculogyric crisis and paroxysmal perceptual alteration in chronic schizophrenic patients--a clinical inquiry into their pathophysiology].
    Watanabe K
    Seishin Shinkeigaku Zasshi; 1991; 93(3):151-89. PubMed ID: 1676849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent episodes of perceptual alteration in patients treated with antipsychotic agents.
    Uchida H; Suzuki T; Tanaka KF; Watanabe K; Yagi G; Kashima H
    J Clin Psychopharmacol; 2003 Oct; 23(5):496-9. PubMed ID: 14520127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy of impaired affect in recovering schizophrenic patients.
    Hogarty GE; McEvoy JP; Ulrich RF; DiBarry AL; Bartone P; Cooley S; Hammill K; Carter M; Munetz MR; Perel J
    Arch Gen Psychiatry; 1995 Jan; 52(1):29. PubMed ID: 7811160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Paroxysmal perceptual alteration in comparison with hallucination--a review of its clinical reports and discussion of its pathophysiological mechanism in the present day, when second generation antipsychotics are widely used].
    Watanabe K
    Seishin Shinkeigaku Zasshi; 2009; 111(2):127-36. PubMed ID: 19378769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of discontinuation of long-term anticholinergic treatment in elderly schizophrenia patients.
    Drimer T; Shahal B; Barak Y
    Int Clin Psychopharmacol; 2004 Jan; 19(1):27-9. PubMed ID: 15101567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic-induced paroxysmal perceptual alteration.
    Uchida H; Suzuki T; Watanabe K; Yagi G; Kashima H
    Am J Psychiatry; 2003 Dec; 160(12):2243-4. PubMed ID: 14638603
    [No Abstract]   [Full Text] [Related]  

  • 9. Color vision impairments in schizophrenia and the role of antipsychotic medication type.
    Fernandes TMP; Silverstein SM; Butler PD; Kéri S; Santos LG; Nogueira RL; Santos NA
    Schizophr Res; 2019 Feb; 204():162-170. PubMed ID: 30201549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
    Silver H; Geraisy N; Schwartz M
    J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual perception in medicated schizophrenic patients.
    Bonnet D; Chabrol H
    Am J Psychiatry; 1997 Apr; 154(4):585; author reply 586-7. PubMed ID: 9090362
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravenous biperiden in akathisia: an open pilot study.
    Hirose S; Ashby CR
    Int J Psychiatry Med; 2000; 30(2):185-94. PubMed ID: 11001281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Testing basic visual functions in the evaluation of extrapyramidal side effects of antipsychotic agents].
    Kéri S; Antal A; Szekeres G; Szendi I; Kovács Z; Janka Z; Benedek G
    Orv Hetil; 1998 Feb; 139(5):235-8. PubMed ID: 9489377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of neuroleptic dosage and extrapyramidal side effects on schizophrenic basic symptoms.
    Moritz S; Krausz M; Gottwalz E; Andresen B
    Compr Psychiatry; 2000; 41(4):284-8. PubMed ID: 10929797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paroxysmal perceptual alteration in a schizophrenic patient treated with paliperidone: A case report.
    Benna P; Rubino E; Marino C; Montalenti E; Giovanna Caprioli M; Rainero I; Pinessi L
    Ann Clin Psychiatry; 2015 Aug; 27(3):223-4. PubMed ID: 26247222
    [No Abstract]   [Full Text] [Related]  

  • 16. Tilt aftereffect reveals early visual processing deficits in Parkinson's disease and in chronic schizophrenic patients on depot neuroleptic.
    Calvert JE; Harris JP; Phillipson OT
    Psychopathology; 1991; 24(6):375-80. PubMed ID: 1685795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dependence on anticholinergics among schizophrenics. Iatrogenic disease or self-medication?].
    Chamorro García L
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1991; 19(6):298-303. PubMed ID: 1687233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of neuroleptic treatment on depressive symptoms in acute schizophrenic episodes.
    Krakowski M; Czobor P; Volavka J
    Psychiatry Res; 1997 Jun; 71(1):19-26. PubMed ID: 9247978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinguishing acute and tardive akathisia by monitoring microvibration: a pilot study.
    Nishikawa T; Kuwahara H; Tsuda A; Tanaka M; Koga I; Uchida Y
    Jpn J Psychiatry Neurol; 1992 Sep; 46(3):665-72. PubMed ID: 1362589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-adrenergic antagonists in psychosis: is improvement due to treatment of neuroleptic-induced akathisia?
    Lipinski JF; Keck PE; McElroy SL
    J Clin Psychopharmacol; 1988 Dec; 8(6):409-16. PubMed ID: 2906947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.